GENetic and clinical predictors of treatment response in depression: the GenPod randomised trial protocol.
BACKGROUND: The most effective pharmacological treatments for depression inhibit the transporters that reuptake serotonin (Selective Serotonin Reuptake Inhibitors - SSRIs) and noradrenaline (Noradrenaline Reuptake Inhibitors - NaRIs) into the presynaptic terminal. There is evidence to suggest that n...
Hlavní autoři: | Thomas, L, Mulligan, J, Mason, V, Tallon, D, Wiles, N, Cowen, P, Nutt, D, O'Donovan, M, Sharp, D, Peters, T, Lewis, G |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2008
|
Podobné jednotky
-
GENetic and clinical Predictors Of treatment response in Depression: the GenPod randomised trial protocol
Autor: O'Donovan Michael, a další
Vydáno: (2008-05-01) -
Severity of depression and response to antidepressants: GENPOD randomised controlled trial.
Autor: Wiles, N, a další
Vydáno: (2012) -
Allowing for non-adherence to treatment in a randomized controlled trial of two antidepressants (citalopram versus reboxetine): an example from the GENPOD trial.
Autor: Wiles, N, a další
Vydáno: (2014) -
Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals.
Autor: Crawford, A, a další
Vydáno: (2014) -
Adverse effects from antidepressant treatment: Randomised controlled trial of 601 depressed individuals
Autor: Crawford, A, a další
Vydáno: (2014)